The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis
NCT ID: NCT01280539
Last Updated: 2012-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2011-01-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENS
Transcutaneous electrical nerve stimulation will be applied on the impaired hand
Transcutaneous electrical nerve stimulation
3 weeks, 5 times a week, 60 minutes a day.
Sham TENS
Sham TENS will be applied to the impaired hand
Transcutaneous electrical nerve stimulation
3 weeks, 5 times a week, 60 minutes a day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous electrical nerve stimulation
3 weeks, 5 times a week, 60 minutes a day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable MS (no relapse during the last 3 months before study onset)
* sensory impairment
* age: between 18 and 68 years old
Exclusion Criteria
18 Years
68 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Provinciale Hogeschool Limburg
OTHER
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Koen Cuypers
Drs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasselt University (BIOMED)
Diepenbeek, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MECU2012-002
Identifier Type: -
Identifier Source: org_study_id